Abstract
Background Once a mainstay of malaria elimination operations, larval source management—the treatment of mosquito breeding habitats–has been marginalized in Africa, due to insufficient effectiveness. However, the development of new technologies, and mosquitoes’ growing resistance to insecticides used in bed nets and house spraying raise renewed interest in this method.
Methods A digitally managed larviciding operation in three of the seven districts of São Tomé and Príncipe (STP) was launched by the Ministry of Health and ZzappMalaria LTD, guided by the Zzapp map-and-GPS mobile application and dashboard. During the operation, quality assurance procedures and field management methods were developed and implemented.
Findings 12,788 water bodies were located and treated a total of 128,864 times. The reduction impact on mosquito population and on malaria cases was 74·90% and 52·65%, respectively. The overall cost per person protected (PPP) was US$0·78 and US$0·41 PPP in the urban areas. Various cost and effectiveness drivers were identified.
Interpretation Digitally managed larviciding can yield highly cost-effective results, especially in urban areas. Digital tools facilitate standardization of operations, implementation of quality assurance procedures, and monitoring of fieldworkers’ performance. Digitally generated spatial data also have the potential to assist integrated vector management operations. A randomized controlled trial with a larger sample is needed to further substantiate findings.
Funding The operation was funded by ZzappMalaria LTD and the STP Ministry of Health (MOH).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The operation was funded by ZzappMalaria LTD and the STP Ministry of Health
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Results of an operation conducted by ZzappMalaria and the Ministry of Health (MOH) of Sao Tome and Principe (STP), using STP MOH data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
